• Iwona Bojar, Radosław Mlak, Iwona Homa-Mlak, Monika Prendecka, Alfred Owoc, and Teresa Małecka-Massalska.
• Department for Woman Health, Institute of Rural Health, Lublin, Poland.
• Arch Med Sci. 2022 Jan 1; 18 (2): 365-375.

IntroductionEvery year over 25 million women worldwide experience menopause symptoms. Menopause leads to the occurrence and intensification of many psychological and somatic disorders including body composition change. Myostatin may play a crucial role in the remodeling of muscle and fat tissue. The aim of the study was to determine the relationship between the level of body fat and the concentration of myostatin protein in serum of peri- or postmenopausal women.Material And MethodsThe study included 300 Caucasian women (in perimenopause or postmenopause). Detailed data were collected at a single time point from all enrolled women. The data included: age, body mass index, hormone replacement therapy and body fat. Measurements of adipose tissue were performed using electronic skinfold calipers. Serum levels of myostatin were determined using a Human Myostatin ELISA Kit.ResultsThe mean myostatin concentration in blood serum was 6.58 ±3.59 ng/ml. The mean percentage of body fat was 32.7 ±6.3 (range: 16.1-50.7). The percentages of women in particular groups of body fat level (I, II, III, IV and V) were 1.7%, 11%, 35.3%, 30.7% and 21.3% respectively. Myostatin level in blood serum was significantly lower (median concentrations: 5.5 vs. 7.0 ng/ml, p = 0.0269) in subjects with higher body fat (groups IV and V) compared to those classified as having a normal or low level of body fat (groups I-III). Myostatin was an independent predictive factor of the occurrence of high body fat (p = 0.0463).ConclusionsDecreased level of myostatin is related to higher level of body fat in peri- and postmenopausal women.Copyright: © 2022 Termedia & Banach.

3 keywords...

hide…